Poor Risk Factor Control And Lower Levels Of Physical Activity Predict Incident Major Cardiovascular Events In Patients With Symptomatic Vertebrobasilar Disease: A Post-hoc Analysis Of The SAMMPRIS Trial

被引：0
|
作者：
Croll, Leah [1 ]
Chang, Andrew [2 ]
Scher, Erica [1 ]
Ishida, Koto [3 ]
Torres, Jose [3 ]
Riina, Howard
Frontera, Jennifer [4 ]
Lord, Aaron [5 ]
Yaghi, Shadi [6 ]
机构：
[1] NYU Langone, Dept Neurol, New York, NY USA
[2] Brown Univ, Warren Alpert Med Sch, Neurol, Providence, RI 02912 USA
[3] NYU, New York, NY 10003 USA
[4] NYU, Clin Affairs Strategy, New York, NY 10003 USA
[5] NYU Langone Brooklyn, New York, NY USA
[6] New York Langone Hosp, New York, NY USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
926
引用
收藏
页数：4
相关论文
共 18 条
  • [1] Poor Risk Factor Control and Lower Levels of Physical Activity Predict Incident Major Cardiovascular Events in Patients With Symptomatic Vertebrobasilar Disease: A Post-Hoc Analysis of the SAMMPRIS Trial
    Croll, Leah
    Chang, Andrew
    Scher, Erica
    Ishida, Koto
    Torres, Jose
    Riina, Howard
    Frontera, Jennifer
    Lord, Aaron
    Yaghi, Shadi
    STROKE, 2020, 51
  • [2] Cardiovascular Risk in Patients With Symptomatic Intracranial Atherosclerosis: A Post-Hoc Analysis of the SAMMPRIS Trial
    Yaghi, Shadi
    de Havenon, Adam
    Scher, Erica
    Chang, Andrew
    Kvernland, Alexandra
    Dehkharghani, Seena
    Rostanski, Sara
    Ishida, Koto
    Torres, Jose
    Fernanine, George
    Merkler, Alexander
    Mac Grory, Brian
    Burton, Tina
    Cutting, Shawna
    Furie, Karen
    STROKE, 2020, 51
  • [3] Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes trial: A post-hoc analysis
    Aso, Yoshimasa
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (08) : 1316 - 1318
  • [4] Red cell distribution width as a predictor of cardiovascular events in high-risk patients with statin intolerance: post-hoc analysis of the CLEAR Outcomes trial
    Safarova, M.
    Li, N.
    Lincoff, A. M.
    Powell, H. A.
    Nissen, S. E.
    Nicholls, S. J.
    Moriarty, P. M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [5] Assessing a tool to predict disease activity in patients with multiple sclerosis: a post-hoc analysis of clinical trial data on patients treated with subcutaneous interferon β-1a
    Freedman, M. S.
    Ben-Amor, A. -F.
    Issard, D.
    Casset-Semanaz, F.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 262 - 262
  • [6] RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS AGED ≥50 YEARS WITH RHEUMATOID ARTHRITIS AND ≥1 ADDITIONAL CARDIOVASCULAR RISK FACTOR: A POST HOC ANALYSIS OF ORAL SURVEILLANCE
    Charles-Schoeman, C.
    Buch, M. H.
    Dougados, M.
    Bhatt, D. L.
    Giles, J. T.
    Ytterberg, S. R.
    Koch, G. G.
    Vranic, I.
    Wu, J.
    Wang, C.
    Menon, S.
    Rivas, J. L.
    Yndestad, A.
    Connell, C. A.
    Szekanecz, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 611 - 612
  • [7] Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events A Post Hoc Analysis of a Randomized Clinical Trial
    Verma, Subodh
    Bain, Stephen C.
    Buse, John B.
    Idorn, Thomas
    Rasmussen, Soren
    Orsted, David D.
    Nauck, Michael A.
    JAMA CARDIOLOGY, 2019, 4 (12) : 1214 - 1220
  • [8] Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance
    Charles-Schoeman, Christina
    Buch, Maya H.
    Dougados, Maxime
    Bhatt, Deepak L.
    Giles, Jon T.
    Ytterberg, Steven R.
    Koch, Gary G.
    Vranic, Ivana
    Wu, Joseph
    Wang, Cunshan
    Kwok, Kenneth
    Menon, Sujatha
    Rivas, Jose L.
    Yndestad, Arne
    Connell, Carol A.
    Szekanecz, Zoltan
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (01) : 119 - 129
  • [9] Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
    Acharjee, Subroto
    Boden, William E.
    Hartigan, Pamela M.
    Teo, Koon K.
    Maron, David J.
    Sedlis, Steven P.
    Kostuk, William
    Spertus, John A.
    Dada, Marcin
    Chaitman, Bernard R.
    Mancini, G. B. John
    Weintraub, William S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (20) : 1826 - 1833
  • [10] Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
    Dransfield, Mark T.
    Criner, Gerard J.
    Halpin, David M. G.
    Han, MeiLan K.
    Hartley, Benjamin
    Kalhan, Ravi
    Lange, Peter
    Lipson, David A.
    Martinez, Fernando J.
    Midwinter, Dawn
    Singh, Dave
    Wise, Robert
    Kunisaki, Ken M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (18):
12